Pfizer To Turn Over Zoloft Research
Pfizer Inc. will turn over some internal research documents on its anti-depressant drug Zoloft to lawyers defending a 15-year-old South Carolina boy accused of murdering his grandparents.
A Pfizer spokesman said Tuesday the New York-based drug company will comply with a South Carolina Circuit Court judge’s order late last week requiring the drug maker to hand over the documents, which contain medical information from clinical trials.
Dr. John Grohol is the CEO and founder of Psych Central. He is an author, researcher and expert in mental health online, and has been writing about online behavior, mental health and psychology issues -- as well as the intersection of technology and human behavior -- since 1992. Dr. Grohol sits on the editorial board of the journal Cyberpsychology, Behavior and Social Networking and is a founding board member and treasurer of the Society for Participatory Medicine.Like this author?
Catch up on other posts by John M. Grohol, PsyD (or subscribe to their feed).
Comments
This post currently has no comments. You can read the comments or leave your own thoughts on our new comments page.
Trackbacks
Last reviewed: By John M. Grohol, Psy.D. on 8 Dec 2004
Published on PsychCentral.com. All rights reserved.
APA Reference
Grohol, J. (2004). Pfizer To Turn Over Zoloft Research. Psych Central. Retrieved on February 14, 2012, from http://psychcentral.com/blog/archives/2004/12/08/pfizer-to-turn-over-zoloft-research/
Grohol, J. (2004). Pfizer To Turn Over Zoloft Research. Psych Central. Retrieved on February 14, 2012, from http://psychcentral.com/blog/archives/2004/12/08/pfizer-to-turn-over-zoloft-research/
